Sanofi reported 15.36B in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
AbbVie USD 5.18B 349M Mar/2025
Aena EUR 950.33M 1.29B Jun/2025
Alcon AG USD 1.41B 4M Jun/2025
Almirall EUR 374.4M 2.7M Mar/2025
Amarin USD 119.52M 1.51M Mar/2025
Amgen USD 8.03B 782M Jun/2025
AstraZeneca USD 7.06B 1.83B Jun/2025
Bayer EUR 4.56B 542M Jun/2025
Biogen USD 2.76B 160.5M Jun/2025
BMW EUR 18.08B 1.6B Jun/2025
Bristol-Myers Squibb USD 12.6B 1.72B Jun/2025
Eli Lilly USD 3.38B 282.6M Jun/2025
Essilor EUR 2.25B 86M Dec/2024
Fresenius EUR 1.23B 1.16B Jun/2025
Fresenius Medical Care EUR 1.72B 644.08M Jun/2025
Galapagos EUR 108.07M 43.83M Mar/2025
Genmab DKK 1.3B 323M Jun/2025
Gilead Sciences USD 5.14B 2.78B Jun/2025
GlaxoSmithKline GBP 3.6B 865M Jun/2025
GRIFOLS EUR 558.69M 194.13M Jun/2025
Hikma Pharmaceutical USD 188M 188M Dec/2024
J&J USD 38.47B 32.35B Mar/2025
Lonza CHF 1.11B 286M Dec/2024
Mercedes-Benz AG EUR 13.94B 2.19B Jun/2025
Merck EUR 1.17B 161M Jun/2025
Merck USD 8.01B 622M Jun/2025
Novartis USD 6.66B 410M Jun/2025
Novo Nordisk A/S 18.44B 5.78B Jun/2025
Orion EUR 259.4M 53.8M Mar/2025
Pfizer USD 1.64B 208M Jun/2025
Philips EUR 1.82B 629M Jun/2025
Recordati EUR 341.55M 8.51M Jun/2025
Regeneron Pharmaceuticals USD 2B 1.09B Jun/2025
Roche Holding CHF 6.98B 2.15B Dec/2024
Sanofi 15.36B 7.37B Jun/2025
Sanofi 15.36B 7.92B Jun/2025
SAP EUR 7.94B 3.4B Jun/2025
UCB EUR 1.57B 1.14B Dec/2024
Vinci EUR 15.07B 130M Jun/2025
Volkswagen EUR 36.76B 3.54B Mar/2025